COI.
close Submit Innovation
close
Pharma verified Verified Outcome TRL 9

Blockchain for Drug Verification (DSCSA)

domain Client: Industry Consortium (Pharma & Wholesale) handshake Provider: Chronicled schedule Deploy: 2022
85 Impact
Enterprise Ready
Evidence Score: A/10
Strength: High

Executive Summary

ANALYST: COI RESEARCH

Implementation of a decentralized blockchain network to verify saleable pharmaceutical returns in compliance with the Drug Supply Chain Security Act (DSCSA).

rate_review Analyst Verdict

"Low Risk. One of the few 'real' enterprise blockchain successes. The Zero-Knowledge Proof (ZKP) architecture allows competitors to verify data validity without sharing proprietary trade secrets."

lock
Full Audit Report Available Includes Risk Register, Technical Specs & Compliance Data.

warning The Challenge

Wholesalers handle millions of returned drugs annually. Under DSCSA, they must verify the product identifier with the manufacturer before reselling. Traditional point-to-point integrations were too slow and exposed private data.

psychology The Solution

Adopted the MediLedger Network (blockchain). It allows wholesalers to scan a barcode and instantly verify its authenticity against the manufacturer's data without centralizing the database.

settings_suggest Technical & Deployment Specs

Integrations
ERP / Edge Scanners
Deployment Model
Blockchain Network
Data Classification
Supply Chain / Serial Numbers
Estimated TCO / ROI
Moderate (Membership)
POC Summary ( to )

"N/A"

shield Risk Register & Mitigation

Risk Factor Severity Mitigation Strategy
Network Adoption Low Already achieved critical mass

trending_up Impact Trajectory

Audited value realization curve

Verifies authenticity in sub-second time Verified Outcome
Primary KPIZero-Knowledge Proofs protect trade secrets
Audit CycleUsed by top wholesalers and pharma manufacturers

policy Compliance & Gov

  • Standards: DSCSA
  • Maturity (TRL): 9
  • Evidence Score: A/10
  • Data Class: Supply Chain / Serial Numbers

folder_shared Verified Assets

description
Verified Case Study
PDF • Version 1
lock
verified_user
Technical Audit
PDF • Audited
lock
Security Architecture

The "Blind Verification" Protocol

How we verified these outcomes for Industry Consortium (Pharma & Wholesale) without exposing sensitive IP or identities.

Private
lock_person

1. Raw Evidence

Audit ID: #PRIV-536
Evidence: Direct SQL Logs
Public
public

2. Verified Asset

Outcome: Verified
Ref ID: #COI-536

Strategic Action Center

Identify your current stage and take the next step.

rocket_launch
Replicate This Success
Want similar results? Request a deployment consultation.
psychology_alt
Submit Challenge
Have a different problem? Submit your problem statement.
publish
Publish Case Study
Submit your own verified evidence.
thumb_up
Verify Impact
Audit your existing solution.